Blog
Are Industrial Products Stocks Lagging ADT (ADT) This Year?
Investors interested in Industrial Products stocks should always be looking to find the best-performing companies in the group. Has ADT (ADT) been one of those stocks this year? By taking a look at
Why Barrick Mining (B) is a Top Value Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Is Sumitomo (SSUMY) a Great Value Stock Right Now?
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With
Here's Why Flowserve (FLS) is a Strong Value Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Are Investors Undervaluing Tutor Perini (TPC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the
Are Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Teva Pharmaceutical Industries Ltd. (TEVA) one of those
Should Value Investors Buy Frontdoor (FTDR) Stock?
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Is Cementos Pacasmayo (CPAC) Stock Undervalued Right Now?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop
Are Consumer Discretionary Stocks Lagging Atlanta Braves Holdings, Inc. (BATRK) This Year?
For those looking to find strong Consumer Discretionary stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Atlanta Braves Holdings (BATRK) been one of
Are Retail-Wholesale Stocks Lagging Expedia Group (EXPE) This Year?
Investors interested in Retail-Wholesale stocks should always be looking to find the best-performing companies in the group. Is Expedia (EXPE) one of those stocks right now? Let's take a closer look
Franklin Resources (BEN) Q4 Earnings and Revenues Beat Estimates
Franklin Resources (BEN) came out with quarterly earnings of $0.67 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.59 per share a year ago. These
James Hardie (JHX) Loses 20.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
James Hardie (JHX) has been beaten down lately with too much selling pressure. While the stock has lost 20.9% over the past four weeks, there is light at the end of the tunnel as it is now in
Down 19.3% in 4 Weeks, Here's Why Grand Canyon Education (LOPE) Looks Ripe for a Turnaround
Grand Canyon Education (LOPE) has been on a downward spiral lately with significant selling pressure. After declining 19.3% over the past four weeks, the stock looks well positioned for a trend
OPENLANE (KAR) Loses 6.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
OPENLANE (KAR) has been on a downward spiral lately with significant selling pressure. After declining 6.9% over the past four weeks, the stock looks well positioned for a trend reversal as it is
AtriCure (ATRC) Loses 13.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
AtriCure (ATRC) has been beaten down lately with too much selling pressure. While the stock has lost 13.6% over the past four weeks, there is light at the end of the tunnel as it is now in oversold
Down 13.5% in 4 Weeks, Here's Why TriNet (TNET) Looks Ripe for a Turnaround
A downtrend has been apparent in TriNet Group (TNET) lately with too much selling pressure. The stock has declined 13.5% over the past four weeks. However, given the fact that it is now in oversold
CRCL Pre-Q3 Earnings Analysis: Should You Hold or Fold the Stock?
Circle Internet Group, Inc. (CRCL) is set to report its third-quarter 2025 results on Nov. 12.
Circle offers USD Coin (USDC), which is redeemable on a one-for-one basis for U.S. dollars. USDC,
Delek US Holdings (DK) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Delek US Holdings (DK) reported $2.89 billion in revenue for the quarter ended September 2025, representing a year-over-year decline of 5.1%. EPS of $1.52 for the same period compares to -$1.45 a
Here's What Key Metrics Tell Us About Koppers (KOP) Q3 Earnings
Koppers (KOP) reported $485.3 million in revenue for the quarter ended September 2025, representing a year-over-year decline of 12.5%. EPS of $1.21 for the same period compares to $1.37 a year ago.
Devon Energy (DVN) Reports Q3 Earnings: What Key Metrics Have to Say
Devon Energy (DVN) reported $4.33 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 7.6%. EPS of $1.04 for the same period compares to $1.10 a year
Warby Parker (WRBY) Reports Q3 Earnings: What Key Metrics Have to Say
Warby Parker Inc. (WRBY) reported $221.68 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 15.2%. EPS of $0.11 for the same period compares to $0.05
Compared to Estimates, ANI (ANIP) Q3 Earnings: A Look at Key Metrics
ANI Pharmaceuticals (ANIP) reported $227.81 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 53.6%. EPS of $2.04 for the same period compares to
Is Archer Aviation (ACHR) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm


